Clinical trial
Metabolic Consequences of Cross-sex Hormonal Treatment in Transgender Persons
NCT04508231 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolic Consequences of Cross-sex Hormonal Treatment in Transgender Persons
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 24, 2020
- Completion date
- December 1, 2021
- Enrollment
- 98 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.